Edwards Lifesciences | EW - Zinsaufwendungen Für Schuld

Aktienkurs
84.15
Täglich Wechseln
4.43 5.56%
Monatlich
1.79%
Jährlich
10.67%
Q2 Prognose
82.35




Zinsaufwendungen Für Schuld Veränderung Datum
Abbott USD 68M 26M 2026-03
Artivion USD 5.53M 589K 2025-12
AtriCure USD 1.33M 17K 2025-09
Baxter International USD 58M 14M 2025-09
Becton, Dickinson and Co. USD 153M 2M 2025-12
Boston Scientific USD 90M 0 2026-03
Cooper Companies USD 22.4M 2M 2025-12
Dexcom USD 4.7M 0 2025-09
Edwards Lifesciences USD 35.9M 2.7M 2025-12
Globus Medical USD 17K 5.1B 2025-12
ICU Medical USD 20.64M 21.39M 2025-12
Inogen 1.03M 384K 2025-03
Insulet USD 9.2M 2.2M 2025-12
Integra LifeSciences USD 23.67M 953K 2025-12
Intuitive Surgical USD 20.11B 58.39B 2026-03
J&J USD 43M 25M 2026-03
Masimo USD 7.5M 1.3M 2025-12
Medtronic USD 181M 0 2025-12
Merit Medical Systems USD 6.36M 390K 2025-12
Stryker USD 157M 46.17B 2025-09
Tandem Diabetes Care USD 2.07M 872.58M 2025-12
Teleflex USD 28.15M 3.69M 2025-12
Zimmer Biomet Holdings USD 71.9M 3.5M 2025-12